Abterra Biosciences, Inc.
San Diego, CA Doing business as Digital Proteomics
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 11588 Sorrento Valley Rd # 16, San Diego, CA 92121, USA
- Website
- abterrabio.com
- Founded
- 2009
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Laboratory and testing services | National Cancer Institute (NIH) | $15,000 | |
| Comprehensive reagents for immunophenotyping rabbit cell-mediated immunity. | National Institute of Allergy and Infectious Diseases (NIH) | $540,608 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Precision Antibody | Columbia, MD | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Novab, Inc. | Tucker, GA | 621511 Medical Laboratories |
| Avantgen Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Abzyme Therapeutics LLC | Pottstown, PA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Bio X Cell, LLC | Lebanon, NH | 325414 Biological Product (except Diagnostic) Manufacturing |
About the company
Abterra Biosciences, Inc. is a company that specializes in antibody discovery and sequencing using next generation sequencing, mass spectrometry, and machine learning. Through federal contract awards, Abterra Biosciences has provided laboratory and testing services to the Department of Health and Human Services National Institutes of Health National Cancer Institute under a $15,000 purchase order. Additionally, the company was awarded a $540,608 firm fixed price definitive contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to deliver comprehensive reagents for immunophenotyping rabbit cell-mediated immunity, in support of research related to allergies and infectious diseases. This contract was designated as a total small business set aside.
Through federal grants, Abterra Biosciences has received funding to develop software for sequencing human antibody proteins from polyclonal immune responses, improve de novo peptide sequencing using machine learning, and enable targeted assembly of specificity determining regions and antibody frameworks. This software aims to identify antibody candidates without requiring a matched B-cell genetic antibody repertoire. The $3,905,928 project is funded by the National Institute of General Medical Sciences under the Biomedical Research and Research Training program. Additionally, the company was awarded $732,147 by the National Institute of General Medical Sciences to develop an intelligent in silico antibody library for therapeutic discovery, incorporating rules of natural antibody development to improve biophysical properties. Abterra Biosciences also received a $217,313 project grant from the National Institute of General Medical Sciences for immune repertoire sequencing error correction, analysis, and visualization.
Quick answers
Is Abterra Biosciences, Inc. registered in SAM.gov?
Yes. Abterra Biosciences, Inc.'s SAM.gov registration is active through September 4, 2027.
What is Abterra Biosciences, Inc.'s CAGE code?
Abterra Biosciences, Inc.'s CAGE code is 6G3U6, and its Unique Entity ID (UEI) is TYHDLNB65NJ1.
What is Abterra Biosciences, Inc.'s most recent federal award?
Abterra Biosciences, Inc.'s most recent federal grant award is A platform for serum antibody repertoire analysis for autoimmune disease diagnosis - systemic lupus erythematosus (SLE)… (R43AI197772), from National Institute of Allergy and Infectious Diseases (NIH), on August 17, 2026.
On GovTribe
See Abterra Biosciences, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors